Replies to post #3693 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>…this, and the initiative for biosimilar drugs, could produce a sea change for GTCB.<

I agree.

I’ll be updating the ReadMeFirst in the next few days with additional entries on the opportunity in the biogeneric / biosimilar / FoB / enhanced-ADCC arena. Regards, Dew